Lifeline for cancer patients: drug continuation study offers hope
NCT ID NCT07172919
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This study allows people with advanced solid tumors who have a specific KRAS gene mutation (G12C) to keep receiving the drug sotorasib (alone or with panitumumab) after their original clinical trial ends. The goal is to monitor safety and side effects for those who are still benefiting. About 14 adults who are already on this treatment in an Amgen-sponsored study can join.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Leon Berard
RECRUITINGLyon, 69008, France
-
Evangelische Lungenklinik
RECRUITINGBerlin, 13125, Germany
-
Florida Cancer Specialists - Fort Myers
RECRUITINGFort Myers, Florida, 33901, United States
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RECRUITINGRoma, 00168, Italy
-
Henry Dunant Hospital Center
RECRUITINGAthens, 11526, Greece
-
National Hospital Organization Hokkaido Cancer Center
RECRUITINGSapporo, Hokkaido, 003-0804, Japan
-
Scientia Clinical Research Ltd
RECRUITINGRandwick, New South Wales, 2031, Australia
-
Taichung Veterans General Hospital
RECRUITINGTaichung, 40705, Taiwan
-
Theagenion Cancer Hospital
RECRUITINGThessaloniki, 54007, Greece
-
Universitaetsspital Basel
RECRUITINGBasel, 4031, Switzerland
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.